Olympus Corporation

Equities

7733

JP3201200007

Advanced Medical Equipment & Technology

Market Closed - Japan Exchange Other stock markets 07:00:00 17/07/2024 BST			5-day change	1st Jan Change
2,682 ^JPY	+2.29%		-0.26%	+31.46%

07-15	Olympus Group Completes Sale of Orthopedic Business to Polaris Capital	MT
07-12	Polaris Capital Group Co., Ltd. acquired Olympus Terumo Biomaterials Corporation and FH Ortho SAS from Olympus Corporation.	CI

Tranche Update on Olympus Corporation's Equity Buyback Plan announced on November 11, 2022.

January 06, 2023 at 06:00 am

From November 11, 2022 to December 31, 2022, the company has repurchased 12,601,000 shares, representing 0.99% for Ã‘33,233.98 million. With this, the company has completed the repurchase of 12,601,000 shares, representing 0.99% for Ã‘33,233.98 million under the buyback announced on November 11, 2022.

Latest news about Olympus Corporation

Olympus Group Completes Sale of Orthopedic Business to Polaris Capital	07-15	MT
Polaris Capital Group Co., Ltd. acquired Olympus Terumo Biomaterials Corporation and FH Ortho SAS from Olympus Corporation.	07-11	CI
Tranche Update on Olympus Corporation's Equity Buyback Plan announced on May 10, 2024.	07-01	CI
Fujifilm once struggled to sell cameras. Now, it can't keep up with demand	06-28	RE
Olympus Corporation and HCL Technologies Limited Expand Engineering and R&D Partnership	06-12	CI
Olympus Completes Disposal of Treasury Shares for Stock Compensation	06-10	MT
Jefferies Adjusts Olympus’ Price Target to 3,100 Yen From 2,500 Yen, Keeps at Buy	06-10	MT
Olympus Skips Buyback in May	06-05	MT
Olympus Enters into Put Option Agreement for Orthopedic Business Transfer	05-27	MT
Olympus' Attributable Profit Soars 69.1% in Fiscal 2024	05-13	MT
Japanese shares fall ahead of earnings reports; rising yields weigh	05-13	RE
Transcript : Olympus Corporation, 2024 Earnings Call, May 10, 2024	05-10
Olympus Corporation announces an Equity Buyback for 60,000,000 shares, representing 5.15% for ¥100,000 million.	05-10	CI
Olympus Corporation authorizes a Buyback Plan.	05-09	CI
Olympus to Return Land and Building to Shenzhen City Government	04-08	MT
Olympus Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024	03-28	CI
Olympus Corporation Announces the Impact of the 2024 Noto Peninsula Earthquake	03-28	CI
Olympus Corporation Announces the Retirement of the Directors	03-28	CI
Olympus Corp. Completes 80 Billion Yen Buyback Program; Will Cancel 3% of Shares Effective April 30	03-27	MT
Tranche Update on Olympus Corporation's Equity Buyback Plan announced on November 9, 2023.	03-26	CI
Olympus Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024	03-25	CI
Olympus Corporation's Equity Buyback announced on November 9, 2023, has closed with 37,446,500 shares, representing 3.11% for ¥79,999.78 million.	03-21	CI
Olympus Backpedals on Taewoong Medical Acquisition	03-11	MT
Olympus Corporation Revises Consolidated Revenue Guidance for the Fiscal Year Ending March 31, 2024	03-01	CI
Grifols appoints new CEO Nacho Abia to the board	02-27	RE

Chart Olympus Corporation

Duration

Period

More charts

Company Profile

Olympus Corporation specializes in manufacturing and marketing of optical and photographic equipments. Net sales break down by family of products as follows: - medical equipments (53.1%): surgical endoscopes, ultrasound endoscopes, etc.; - medical devices (31.7%): medical devices for gastroenterology, urology, respiratory management, ENT and gynecology; - scientific analysis instruments and microscopes (13.7%); - other (1.5%): biomedical materials, orthopedic equipment, etc. Net sales break down geographically as follows: Japan (15.6%), China (14.4%), Asia and Oceania (8.9%), North America (33.8%), Europe (25.1%) and other (2.2%).

Sector

Advanced Medical Equipment & Technology

Calendar

06/08/2024 - Q1 2024 Earnings Release

Related indices

Nikkei 225

More about the company

Income Statement Evolution

More financial data

Ratings for Olympus Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2,622 JPY

Average target price

2,759 JPY

Spread / Average Target

+5.22%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
OLYMPUS CORPORATION	+31.46%	19.28B
THERMO FISHER SCIENTIFIC	+4.64%	212B
DANAHER CORPORATION	+8.99%	187B
INTUITIVE SURGICAL, INC.	+29.83%	155B
BOSTON SCIENTIFIC CORPORATION	+35.17%	115B
SIEMENS HEALTHINEERS AG	+1.90%	65.5B
EDWARDS LIFESCIENCES CORPORATION	+15.06%	52.87B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.47%	45.25B
AGILENT TECHNOLOGIES, INC.	-2.14%	39.7B
GE HEALTHCARE TECHNOLOGIES INC.	+6.88%	37.72B

Other Advanced Medical Equipment & Technology